Asymmetrex® Awarded $1.8M NIH-NHLBI SBIR Phase II Grant to Manufacture First Differential Tissue Stem Cell Counter
Asymmetrex® was awarded a $1.8M NHLBI grant to develop an instrument for automated determination of the differential stem cell count of tissue cell samples. BOSTON, MA, UNITED STATES, October 2, 2024 /EINPresswire.com/ -- Determining the …